Veracyte, Inc. (VCYT) News
Latest headlines that mention VCYT, newest first · each headline opens the original publisher
- Last price
- $43.12
- Day change
- -2.86%
- Next earnings
- 2026-11-04 AMC
VCYT headlines
latest coverageThis genomic diagnostics company saw a notable insider sale, as shares have surged over 70% in the past year.
This genomics diagnostics specialist, up over 120% in a year, reported a notable insider sale amid ongoing scheduled dispositions.
Veracyte opened its doors with a simple theory: Not all cancer patients need surgery or chemotherapy. Now, Veracyte stock is on a run. The post This Top Stock Has Surged. CEO Explains Key To Veracyte's Success. appeared first on Investor's Business Daily .
Also mentioned with VCYT
30d
Headlines that tag both tickers
VCYT news alerts
Get an alert by email or push when a new headline mentions VCYT.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.